Tomaszek Lucyna, Fenikowski Dariusz, Gawron Danuta, Komotajtys Halina
Department of Thoracic Surgery, Institute for Tuberculosis and Lung Diseases, Pediatric Division, Rabka-Zdroj, Poland.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2019 Dec;163(4):366-373. doi: 10.5507/bp.2018.072. Epub 2018 Nov 16.
(1) To compare the efficacy of bupivacaine/fentanyl and ropivacaine/fentanyl for postoperative pain control (2). To identify the predictors of acute post-operative pain at rest, during deep breathing and coughing.
The study was performed in patients aged 6-18 years after thoracic surgery. The subjects were randomized to the bupivacaine 0.125%/fentanyl 5.0 μg/mL (n=46) or ropivacaine 0.2%/fentanyl 5.0 μg/mL (n=48) group; analgesic mixtures were administered through epidural catheter. All the patients received paracetamol and non-steroidal anti-inflammatory drugs. The observation period after surgery lasted 72 h. Pain intensity was assessed at rest, during deep breathing and coughing and was based on the Numerical Rating Scale and the FLACC scale (range 0-10). If the pain was above 2/10, the analgesia was modified.
Median pain scores at rest (0.4 vs. 0.5), during deep breathing (0.3 vs. 0.3) and coughing (0.6 vs. 0.6) were comparable in BF and RF group. The intensity of pain at rest was associated with the number of drains inserted into the thorax (β=0.39), the number of pain intensity measurements (β=0.36) and the number of nursing interventions undertaken to relieve pain (β=0.16). Pain intensity at rest determined the intensity of pain during deep breathing (β=0.60), which in turn decided on the severity of pain during coughing (β=0.80). The intensity of pain was increased by age.
Thoracic epidural bupivacaine/fentanyl provided adequate pain relief and similar analgesia to ropivacaine/fentanyl. The effectiveness of analgesia depended on the number of pain measurements and interventions by nurses to relieve the pain.
ClinicalTrials.gov; Multimodal Analgesia in Children and Adolescents After the Ravitch Procedure and Thoracotomy; NCT03444636; https://clinicaltrials.gov/ct2/show/NCT03444636.
(1)比较布比卡因/芬太尼和罗哌卡因/芬太尼用于术后疼痛控制的疗效。(2)确定术后静息、深呼吸和咳嗽时急性疼痛的预测因素。
本研究在6至18岁接受胸外科手术的患者中进行。受试者被随机分为布比卡因0.125%/芬太尼5.0μg/mL组(n = 46)或罗哌卡因0.2%/芬太尼5.0μg/mL组(n = 48);镇痛合剂通过硬膜外导管给药。所有患者均接受对乙酰氨基酚和非甾体类抗炎药。术后观察期持续72小时。根据数字评分量表和面部表情、腿部活动、活动、哭泣和安慰量表(FLACC量表,范围0至10)评估静息、深呼吸和咳嗽时的疼痛强度。如果疼痛评分高于2/10,则调整镇痛方案。
布比卡因/芬太尼组和罗哌卡因/芬太尼组静息时(0.4对0.5)、深呼吸时(0.3对0.3)和咳嗽时(0.6对0.6)的疼痛评分中位数相当。静息时的疼痛强度与插入胸腔的引流管数量(β = 0.39)、疼痛强度测量次数(β = 0.36)以及为缓解疼痛而进行的护理干预次数(β = 0.16)相关。静息时的疼痛强度决定了深呼吸时的疼痛强度(β = 0.60),而深呼吸时的疼痛强度又决定了咳嗽时的疼痛严重程度(β = 0.80)。疼痛强度随年龄增加。
胸段硬膜外使用布比卡因/芬太尼与罗哌卡因/芬太尼提供的疼痛缓解效果相当,镇痛效果相似。镇痛效果取决于疼痛测量次数以及护士为缓解疼痛所采取的干预措施。
ClinicalTrials.gov;拉维奇手术和开胸术后儿童及青少年的多模式镇痛;NCT03444636;https://clinicaltrials.gov/ct2/show/NCT03444636 。